December 23, 2011 — Biotronik announced the first implantations of the new Lumax 740 implantable cardiac defibrillators — the world’s first and only ICDs eligible for use with magnetic resonance imaging (MRI). The devices — for patients with tachyarrhythmias — feature ProMRI, an MR Conditional feature, combined with an extended device longevity and Biotronik Home Monitoring.


December 23, 2011 — A new report from KLAS reveals that the cardiology IT market is moving toward consolidation. The report, Cardiology 2012: Will the Complete CVIS Please Stand Up?, explains that as a result of this trend, providers are looking for a technology leader to step up and meet their needs. It examines which vendors that providers feel are poised to lead the cardiology market, provide necessary functionality, and offer integration.

December 23, 2011 - Philips Healthcare said Medical City Dallas Hospital, Dallas, Texas, is the first hospital in the United States to use Philips’ HeartNavigator interventional tool in clinical practice. HeartNavigator is a new procedure planning and image guidance tool to help interventional cardiologists and cardiac surgeons perform minimally invasive heart valve replacements. Developed in cooperation with partner hospitals around the world, HeartNavigator is designed to increase the objectivity of the procedure planning and to simplify the procedure itself.

December 22, 2011 — TriVascular Inc. announced the first Canadian patients treated with its Ovation Abdominal Stent Graft. The ultra-low profile (14F OD) system is designed to expand the patient population suitable for endovascular aortic repair (EVAR) by addressing a wider range of diseased anatomy. Cherrie Abraham, M.D., vascular surgery, McGill University, performed the first case in Canada at Montreal Jewish General Hospital (JGH). The second case, also performed at JGH, was performed by Daniel Obrand, M.D., chief of vascular surgery, JGH.

December 22, 2011 — The Heart Hospital Baylor Plano became the first hospital in the world to perform an electrophysiology procedure last week using the new Epoch platform. This technology increases efficiency with a fully remote, networked and modular robotic magnetic solution, which enables greater surgical precision and improved catheter control while reducing the risk of complications.

December 22 2011 — A recent United States study on the importance of measuring rates of rehospitalization following percutaneous coronary intervention (PCI) has drawn the attention of the European Society of Cardiology (ESC). The research, published in the JACC Cardiovascular Interventions, represents one of the first studies to explore PCI readmissions. According to ESC, it highlights the need for similar studies to be initiated across Europe to improve patient care.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now